TY - CHAP A1 - Junichi Taki A2 - Hiroshi Wakabayashi A3 - Anri Inaki A4 - Ichiro Matsunari A5 - Seigo Kinuya ED1 - Ali Gholamrezanezhad Y1 - 2011-12-22 PY - 2011 T1 - Apoptosis Imaging in Diseased Myocardium N2 - The development of nuclear medicine as a medical specialty has resulted in the large-scale application of its effective imaging methods in everyday practice as a primary method of diagnosis. The introduction of positron-emitting tracers (PET) has represented another fundamental leap forward in the ability of nuclear medicine to exert a profound impact on patient management, while the ability to produce radioisotopes of different elements initiated a variety of tracer studies in biology and medicine, facilitating enhanced interactions of nuclear medicine specialists and specialists in other disciplines. At present, nuclear medicine is an essential part of diagnosis of many diseases, particularly in cardiologic, nephrologic and oncologic applications and it is well-established in its therapeutic approaches, notably in the treatment of thyroid cancers. Data from official sources of different countries confirm that more than 10-15 percent of expenditures on clinical imaging studies are spent on nuclear medicine procedures. BT - 12 Chapters on Nuclear Medicine SP - Ch. 10 UR - https://doi.org/10.5772/25292 DO - 10.5772/25292 SN - PB - IntechOpen CY - Rijeka Y2 - 2020-08-07 ER -